The study, published in Annals of Family Medicine, created a classifier called NoMicro that does not depend on urine microscopy to predict urine cultures. The model used predictor variables including age, gender, dipstick urinalysis nitrites, leukocytes, clarity, glucose, protein, blood, dysuria, abdominal pain and a history of urinary tract infections. The retrospectively validated model used 80,387 emergency department data sets and 472 primary care data sets to prove accuracy.
Researchers say NoMicro could be used to safely withhold antibiotics for low-risk patients and prevent antibiotic overuse.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.